PTC Therapeutics, Inc.

38
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US69366J2006
USD
77.85
-0.65 (-0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
PTC Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-363.00
-696.00
-587.00
-518.00
-402.00
-239.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
100.00
-4.00
-94.00
-23.00
36.00
20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-107.00
-158.00
-356.00
-251.00
-194.00
-98.00
Cash Flow from Investing Activities
44.00
-176.00
290.00
219.00
-561.00
-387.00
Cash Flow from Financing Activities
255.00
646.00
167.00
20.00
668.00
613.00
Net Cash Inflow / Outflow
185.00
314.00
98.00
-19.00
-79.00
126.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-7.00
3.00
-2.00
-7.00
7.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PTC Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-363.119
-845.687
482.00
57.06%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
100.743
16.811
84.00
499.27%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-107.688
-582.453
475.00
81.51%
Cash Flow from Investing Activities
44.182
-244.974
288.00
118.04%
Cash Flow from Financing Activities
255.866
677.774
-422.00
-62.25%
Net Cash Inflow / Outflow
185.032
-149.578
334.00
223.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-7.328
0.075
-7.00
-9870.67%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 32.02% vs 55.58% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-107.69
-158.42
32.02%